• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食品添加剂会抑制肠道药物转运体,但对体外药物渗透性的影响有限。

Food Additives Inhibit Intestinal Drug Transporters but Have Limited Effect on In Vitro Drug Permeability.

作者信息

Suominen Laura, Stenberg Emilia, Sjöstedt Noora, Kidron Heidi

机构信息

Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki FI-00014, Finland.

出版信息

Mol Pharm. 2025 Sep 1;22(9):5627-5637. doi: 10.1021/acs.molpharmaceut.5c00705. Epub 2025 Aug 7.

DOI:10.1021/acs.molpharmaceut.5c00705
PMID:40773056
Abstract

Food additives are chemical substances that are added to processed food to improve its flavor, texture, or appearance. Food additives can inhibit intestinal transporters, such as breast cancer resistance protein (BCRP), multidrug resistance associated protein 2 (MRP2), organic anion transporting polypeptide 2B1 (OATP2B1), and P-glycoprotein (P-gp). This inhibition could potentially affect the absorption of their substrate drugs and cause unwanted food-drug interactions. In this study, 22 food additives were evaluated for their impact on BCRP, MRP2, OATP2B1, and P-gp transport. The inhibition potency toward intestinal transporters was first studied using membrane vesicles and HEK293 cells. In these assays, four food additives (beta-carotene, butylated hydroxytoluene, dodecyl gallate, and octyl gallate) were identified as inhibitors. Seven food additives (allura red AC, beta-carotene, brilliant blue FCF, carmoisine, neohesperidin DC, sunset yellow FCF, and tartrazine), which were identified as inhibitors either in the current study or in our previous studies, were selected for Caco-2 permeability studies to further evaluate their possible effect on drug absorption. None of the selected food additives showed any effect on sulfasalazine permeability. These results suggest that the selected food additives are inhibitors of the studied transporters but are unlikely to cause clinically significant intestinal transporter-mediated drug interactions.

摘要

食品添加剂是添加到加工食品中以改善其风味、质地或外观的化学物质。食品添加剂可抑制肠道转运蛋白,如乳腺癌耐药蛋白(BCRP)、多药耐药相关蛋白2(MRP2)、有机阴离子转运多肽2B1(OATP2B1)和P-糖蛋白(P-gp)。这种抑制作用可能会影响其底物药物的吸收,并导致不良的食物-药物相互作用。在本研究中,评估了22种食品添加剂对BCRP、MRP2、OATP2B1和P-gp转运的影响。首先使用膜囊泡和HEK293细胞研究了对肠道转运蛋白的抑制效力。在这些试验中,四种食品添加剂(β-胡萝卜素、丁基羟基甲苯、十二烷基没食子酸酯和辛基没食子酸酯)被鉴定为抑制剂。七种食品添加剂(诱惑红AC、β-胡萝卜素、亮蓝FCF、胭脂红、新橙皮苷二氢查耳酮、日落黄FCF和柠檬黄),在本研究或我们之前的研究中被鉴定为抑制剂,被选用于Caco-2通透性研究,以进一步评估它们对药物吸收的可能影响。所选食品添加剂均未对柳氮磺胺吡啶的通透性产生任何影响。这些结果表明,所选食品添加剂是所研究转运蛋白的抑制剂,但不太可能引起临床上显著的肠道转运蛋白介导的药物相互作用。

相似文献

1
Food Additives Inhibit Intestinal Drug Transporters but Have Limited Effect on In Vitro Drug Permeability.食品添加剂会抑制肠道药物转运体,但对体外药物渗透性的影响有限。
Mol Pharm. 2025 Sep 1;22(9):5627-5637. doi: 10.1021/acs.molpharmaceut.5c00705. Epub 2025 Aug 7.
2
Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.由多药耐药相关蛋白2(MRP2)和乳腺癌耐药蛋白(BCRP)介导的小肠外排作用将柳氮磺胺吡啶的肠道通透性从高转变为低,从而实现其结肠靶向性。
Am J Physiol Gastrointest Liver Physiol. 2009 Aug;297(2):G371-7. doi: 10.1152/ajpgi.00102.2009. Epub 2009 Jun 18.
3
In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor.体外研究药物转运体和代谢酶在多拉韦林(一种 HIV 整合酶抑制剂)处置和药物相互作用中的作用。
Drug Metab Dispos. 2013 Feb;41(2):353-61. doi: 10.1124/dmd.112.048918. Epub 2012 Nov 6.
4
Minimal Involvement of P-gp and BCRP in Oral Absorption of Ensitrelvir, An Oral SARS-CoV-2 3C-like Protease Inhibitor, in a Non-Clinical Investigation.在一项非临床研究中,口服 SARS-CoV-2 3C 样蛋白酶抑制剂恩赛特韦的口服吸收中 P-糖蛋白和 BCRP 的参与程度极小。
J Pharm Sci. 2024 Sep;113(9):2871-2878. doi: 10.1016/j.xphs.2024.06.009. Epub 2024 Jun 15.
5
Regulation of Blood-Brain Barrier Transporters by Transforming Growth Factor-/Activin Receptor-Like Kinase 1 Signaling: Relevance to the Brain Disposition of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors (i.e., Statins).转化生长因子-/激活素受体样激酶 1 信号对血脑屏障转运体的调节:与 3-羟基-3-甲基戊二酰辅酶 A 还原酶抑制剂(即他汀类药物)在脑部分布的相关性。
Drug Metab Dispos. 2022 Jul;50(7):942-956. doi: 10.1124/dmd.121.000781. Epub 2022 May 3.
6
The H2 receptor antagonist nizatidine is a P-glycoprotein substrate: characterization of its intestinal epithelial cell efflux transport.H2受体拮抗剂尼扎替丁是一种P-糖蛋白底物:其肠上皮细胞外排转运的特征
AAPS J. 2009 Jun;11(2):205-13. doi: 10.1208/s12248-009-9092-5. Epub 2009 Mar 25.
7
A Pilot Study To Assess the Suitability of Riboflavin As a Surrogate Marker of Breast Cancer Resistance Protein in Healthy Participants.一项评估核黄素作为健康受试者中乳腺癌耐药蛋白替代标志物适用性的初步研究。
J Pharmacol Exp Ther. 2024 Jul 18;390(2):162-173. doi: 10.1124/jpet.123.002015.
8
Characterization of three B-cell lymphoma cell lines from chemotherapy resistant patients with respect to in vitro sensitivity to 21 antitumor agents, ABC-transporter expression and cellular redox status.对三名化疗耐药患者的B细胞淋巴瘤细胞系进行体外对21种抗肿瘤药物的敏感性、ABC转运蛋白表达及细胞氧化还原状态的特征分析。
J Cancer Res Clin Oncol. 2007 Dec;133(12):957-67. doi: 10.1007/s00432-007-0241-x. Epub 2007 Jun 12.
9
In vitro and in silico evaluation of the interaction of yohimbine with drug transporters and cytochrome P450 isoenzymes.育亨宾与药物转运体及细胞色素P450同工酶相互作用的体外和计算机模拟评估。
Eur J Pharmacol. 2025 Sep 15;1003:177869. doi: 10.1016/j.ejphar.2025.177869. Epub 2025 Jun 23.
10
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险

本文引用的文献

1
Preincubation-dependent inhibition of organic anion transporting polypeptide 2B1.依赖预孵育的有机阴离子转运多肽 2B1 抑制作用
Eur J Pharm Sci. 2024 Sep 1;200:106852. doi: 10.1016/j.ejps.2024.106852. Epub 2024 Jul 15.
2
Effect of Antioxidants in Medicinal Products on Intestinal Drug Transporters.药用产品中抗氧化剂对肠道药物转运体的影响。
Pharmaceutics. 2024 May 10;16(5):647. doi: 10.3390/pharmaceutics16050647.
3
Low β-carotene bioaccessibility and bioavailability from high fat, dairy-based meal.高脂肪、基于乳制品的膳食中β-胡萝卜素生物利用率和生物可及性低。
Eur J Nutr. 2024 Sep;63(6):2261-2270. doi: 10.1007/s00394-024-03423-w. Epub 2024 May 16.
4
The Inhibitor Preincubation Effect Is Universal to SLC Transporter Assays and Is Only Partially Eliminated in the Presence of Extracellular Protein.抑制剂预孵育效应在 SLC 转运体测定中是普遍存在的,并且仅在外周蛋白存在时部分消除。
Drug Metab Dispos. 2023 Aug;51(8):982-994. doi: 10.1124/dmd.122.001191. Epub 2023 May 19.
5
Food Additives in Ultra-Processed Packaged Foods: An Examination of US Household Grocery Store Purchases.超加工包装食品中的食品添加剂:对美国家庭杂货店购买情况的调查。
J Acad Nutr Diet. 2023 Jun;123(6):889-901. doi: 10.1016/j.jand.2022.11.007. Epub 2023 Jan 31.
6
Preincubation Time-Dependent, Long-Lasting Inhibition of Drug Transporters and Impact on the Prediction of Drug-Drug Interactions.预孵育时间依赖性、长时程的药物转运体抑制作用及其对药物相互作用预测的影响。
Drug Metab Dispos. 2023 Sep;51(9):1077-1088. doi: 10.1124/dmd.122.000970. Epub 2023 Feb 28.
7
Drug metabolism and drug transport of the 100 most prescribed oral drugs.100 种最常开出的口服药物的药物代谢和药物转运。
Basic Clin Pharmacol Toxicol. 2022 Nov;131(5):311-324. doi: 10.1111/bcpt.13780. Epub 2022 Aug 24.
8
Experimental and Modeling Evidence Supporting the -Inhibition Mechanism for Preincubation Time-Dependent, Long-Lasting Inhibition of Organic Anion Transporting Polypeptide 1B1 by Cyclosporine A.支持环孢素A对有机阴离子转运多肽1B1进行预孵育时间依赖性、长效抑制的抑制机制的实验和模型证据。
Drug Metab Dispos. 2022 May;50(5):541-551. doi: 10.1124/dmd.121.000783. Epub 2022 Mar 3.
9
Interaction of Commonly Used Oral Molecular Excipients with P-glycoprotein.常用口服分子赋形剂与 P-糖蛋白的相互作用。
AAPS J. 2021 Sep 15;23(5):106. doi: 10.1208/s12248-021-00631-8.
10
Inhibition of ABCG2/BCRP-mediated transport-correlation analysis of various expression systems and probe substrates.ABCG2/BCRP介导转运的抑制作用——各种表达系统与探针底物的相关性分析
Eur J Pharm Sci. 2021 Jan 1;156:105593. doi: 10.1016/j.ejps.2020.105593. Epub 2020 Oct 13.